C
CMPS
Compass Pathways Plc
14.20
+0.87+6.53%After Hours: 14.15 -0.05 -0.35%19:59 08/24 EDT
OPEN/PREV CLOSE13.41/13.33
TODAY RANGE13.08-14.32
VOL2.78M
MARKET CAP1.97B
52 WEEK RANGE4.400-15.40
AVG VOL (3M)3.70M
% TURNOVER2.00%
TURNOVER--
P/E (TTM)-4.0894
% RANGE9.30%
EPS(TTM)-3.4724
P/E(FORWARD)-6.6006
P/B22.80
BVPS0.6228
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.82B
SHARES OUTSTANDING138.48M
NEXT EARNINGS11/02-11/06
FREE FLOAT127.92M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
Simply Wall St·4d ago
How COMPASS Pathways’ VA Psilocybin Trial (CMPS) Has Reframed Its Veteran Mental Health Ambitions
Simply Wall St·6d ago
COMPASS Pathways (CMPS) Following VA Trial News The Valuation Narrative Is Back In Focus
Seeking Alpha·6d ago
Ibogaine could rise as potential psychedelic treatment with Trump announcement
Simply Wall St·08/13 09:35
Should VA-Backed PIVOT Trial on COMP360 in Veterans Require Action From COMPASS Pathways (CMPS) Investors?
TipRanks·08/10 12:45
COMPASS Pathways (CMPS) Gets a Buy from Evercore ISI
Simply Wall St·08/09 15:35
COMPASS Pathways (CMPS) Joins VA PIVOT Trial, Is The Stock Still Cheap?
Simply Wall St·08/07 17:44
COMPASS Pathways (CMPS) Stock Looks Stretched Following Its 214% One Year Run
TipRanks·08/07 13:40
Unusually active option classes on open August 7th
Dow Jones·08/07 10:51
Compass Pathways Price Target Cut to $65.00/Share From $70.00 by HC Wainwright & Co.
Dow Jones·08/07 10:51
Compass Pathways Is Maintained at Buy by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price